RT @Hologic: NEW – The Trans-aTTom study validated the ability of BCI to predict benefit from extended tamoxifen in early-stage HR+breast c…
2,372 followers
895 followers
RT @Hologic: NEW – The Trans-aTTom study validated the ability of BCI to predict benefit from extended tamoxifen in early-stage HR+breast c…
7,391 followers
NEW – The Trans-aTTom study validated the ability of BCI to predict benefit from extended tamoxifen in early-stage HR+breast cancer. Results from the expanded Trans-aTTom cohort are now published in Clinical Cancer Research https://t.co/ENxel9MVyz https://
895 followers
RT @Hologic: Final results from the Trans-aTTom study further strengthen the evidence supporting @BreastCancerNDX's ability to predict bene…